Ratings Alignment Healthcare, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/09/2024 BST			5-day change	1st Jan Change
11.89 ^USD	+2.68%		+25.16%	+38.10%

08-16	Alignment Healthcare, Inc. Announces Board and Committee Changes	CI
08-02	UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating	MT

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
The company appears highly valued given the size of its balance sheet.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Source: Surperformance

Source: Refinitiv

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Capi. ($)
ALIGNMENT HEALTHCARE, INC.	-	2.27B
UNITEDHEALTH GROUP INC.		549B
ELEVANCE HEALTH, INC.		128B
CIGNA		102B
CENTENE CORPORATION		39.64B
HUMANA INC.		38.72B
MOLINA HEALTHCARE, INC.		20.99B
PROGYNY, INC.		2.18B
CLOVER HEALTH INVESTMENTS, CORP.	-	1.49B
Average		98.2B
Weighted average by Cap.